初级中枢神经系统淋巴瘤:一个7年的单中心经验
Etienne Dugast1, Cédric Aumont2, Ilyess Zemmoura1
1Department of Neurosurgery, CHRU de Tours, Tours, France; Inserm, UMR 1253, Imaging and Brain (iBrain), Université de Tours, Tours, France.
Neuro-Chirurgie
|June 22, 2025
概括
诊断原发性中枢神经系统淋巴瘤 (PCNSL) 涉及MRI和活检,但生物标志物如脑脊液 (CSF) 或玻璃体幽默中的互白素水平和免疫类型可以帮助诊断,特别是当活检具有挑战性时.
科学领域:
- 神经瘤学神经瘤学
- 血液学 血液学 血液学
- 眼科医生 眼科 眼科
背景情况:
- 主要中枢神经系统淋巴瘤 (PCNSL) 是一种罕见的恶性瘤,影响大脑,脑膜或眼睛.
- 高剂量的甲状腺素改善了PCNSL患者的生存率.
- 诊断通常依赖于对比增强的MRI和脑活检,尽管生物标志物提供了补充诊断价值.
研究的目的:
- 评估初级中枢神经系统淋巴瘤 (PCNSL) 的诊断特征.
- 评估MRI,眼科检查,脑活检和PCNSL诊断中的生物标志物的有用性.
- 分析成年PCNSL患者队列中的诊断方法.
主要方法:
- 65名成年PCNSL患者 (2017-2023) 的回顾性观察研究.
- 分析MRI特征,眼科检查结果和大脑活检结果.
- 从脑脊液 (CSF) 和玻璃体中获取的生物标志物数据的评估,包括淋巴细胞免疫类型和互白素水平 (IL-6,IL-10).
主要成果:
- 大脑活检在52%的病例中证实了PCNSL,并且仍然是黄金标准.
- 在17%的玻璃体样本和14%的脊髓样本中,通过免疫型定型获得了细胞学确认.
- 在5-6%的患者中,单独高白素水平引导治疗,而6%的患者根据临床和MRI发现接受治疗.
结论:
- 通过多种方法来确立PCNSL诊断,以脑活检为黄金标准.
- 生物标记物,如白素水平,是有价值的补充工具,而不是主要的诊断方法.
- 实施标准化诊断协议对于快速诊断和及时治疗至关重要,最终可以改善患者的治疗结果.
更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.8K
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
7.3K
相关概念视频
Primary Lymphoid Organs
7.3K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
7.3K
Secondary Lymphoid Organs
4.0K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
4.0K
Lymphoid Cells and Tissues
1.6K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
